A detailed history of Barclays PLC transactions in Icu Medical Inc stock. As of the latest transaction made, Barclays PLC holds 59,207 shares of ICUI stock, worth $9.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
59,207
Previous 59,207 -0.0%
Holding current value
$9.28 Million
Previous $10.8 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$114.88 - $182.17 $920,188 - $1.46 Million
8,010 Added 15.65%
59,207 $10.8 Million
Q2 2024

Aug 14, 2024

SELL
$94.53 - $120.55 $42,822 - $54,609
-453 Reduced 0.88%
51,197 $6.08 Million
Q1 2024

May 15, 2024

BUY
$86.88 - $112.48 $4.09 Million - $5.3 Million
47,081 Added 1030.44%
51,650 $5.54 Million
Q4 2023

Feb 15, 2024

SELL
$81.08 - $119.29 $448,534 - $659,912
-5,532 Reduced 54.77%
4,569 $455,000
Q3 2023

Nov 07, 2023

SELL
$115.27 - $182.23 $5.18 Million - $8.2 Million
-44,981 Reduced 81.66%
10,101 $1.2 Million
Q2 2023

Aug 03, 2023

SELL
$161.03 - $209.15 $1.96 Million - $2.54 Million
-12,150 Reduced 18.07%
55,082 $9.81 Million
Q1 2023

May 04, 2023

BUY
$153.15 - $198.21 $7.89 Million - $10.2 Million
51,513 Added 327.71%
67,232 $11.1 Million
Q4 2022

Feb 13, 2023

SELL
$136.25 - $165.56 $4.93 Million - $5.99 Million
-36,185 Reduced 69.72%
15,719 $2.48 Million
Q3 2022

Nov 03, 2022

BUY
$149.44 - $188.1 $7.23 Million - $9.1 Million
48,368 Added 1367.87%
51,904 $7.82 Million
Q2 2022

Aug 12, 2022

SELL
$161.4 - $229.7 $4.58 Million - $6.52 Million
-28,402 Reduced 88.93%
3,536 $581,000
Q1 2022

May 16, 2022

BUY
$203.51 - $247.46 $5.11 Million - $6.21 Million
25,108 Added 367.61%
31,938 $7.11 Million
Q4 2021

Feb 14, 2022

SELL
$220.96 - $247.44 $31.2 Million - $34.9 Million
-141,099 Reduced 95.38%
6,830 $1.62 Million
Q3 2021

Nov 09, 2021

BUY
$186.8 - $260.0 $20.9 Million - $29.2 Million
112,126 Added 313.17%
147,929 $34.5 Million
Q2 2021

Aug 13, 2021

BUY
$190.83 - $215.73 $2.49 Million - $2.82 Million
13,057 Added 57.4%
35,803 $7.37 Million
Q1 2021

May 13, 2021

BUY
$197.58 - $222.54 $4.2 Million - $4.73 Million
21,239 Added 1409.36%
22,746 $4.67 Million
Q4 2020

Feb 11, 2021

SELL
$177.6 - $214.65 $2.68 Million - $3.24 Million
-15,082 Reduced 90.92%
1,507 $324,000
Q3 2020

Nov 12, 2020

SELL
$177.7 - $200.24 $984,102 - $1.11 Million
-5,538 Reduced 25.03%
16,589 $3.03 Million
Q2 2020

Aug 12, 2020

SELL
$172.31 - $230.89 $3.45 Million - $4.62 Million
-20,007 Reduced 47.48%
22,127 $4.08 Million
Q1 2020

May 13, 2020

BUY
$160.04 - $216.15 $2.41 Million - $3.26 Million
15,086 Added 55.77%
42,134 $8.5 Million
Q4 2019

Feb 10, 2020

BUY
$151.88 - $189.51 $1.75 Million - $2.18 Million
11,520 Added 74.19%
27,048 $5.06 Million
Q3 2019

Nov 14, 2019

BUY
$154.21 - $257.38 $1.54 Million - $2.57 Million
9,992 Added 180.49%
15,528 $2.48 Million
Q2 2019

Aug 14, 2019

BUY
$212.8 - $251.91 $356,014 - $421,445
1,673 Added 43.31%
5,536 $1.39 Million
Q1 2019

May 15, 2019

SELL
$221.09 - $253.28 $5.98 Million - $6.85 Million
-27,043 Reduced 87.5%
3,863 $924,000
Q4 2018

Feb 14, 2019

BUY
$213.13 - $281.01 $3.53 Million - $4.66 Million
16,568 Added 115.55%
30,906 $7.1 Million
Q3 2018

Nov 14, 2018

SELL
$265.5 - $307.63 $5.36 Million - $6.2 Million
-20,170 Reduced 58.45%
14,338 $4.05 Million
Q2 2018

Aug 14, 2018

BUY
$245.65 - $309.75 $7.02 Million - $8.86 Million
28,590 Added 483.1%
34,508 $10.1 Million
Q1 2018

May 15, 2018

BUY
$213.2 - $261.85 $670,087 - $822,994
3,143 Added 113.26%
5,918 $1.49 Million
Q4 2017

Feb 14, 2018

BUY
$186.1 - $220.45 $407,559 - $482,785
2,190 Added 374.36%
2,775 $599,000
Q3 2017

Nov 14, 2017

BUY
$164.9 - $187.15 $96,466 - $109,482
585
585 $109,000

Others Institutions Holding ICUI

About ICU MEDICAL INC


  • Ticker ICUI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 23,899,400
  • Market Cap $3.75B
  • Description
  • ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and Swa...
More about ICUI
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.